- Nachrichtendetail
-
16.05.2024 13:48:21 - dpa-AFX: *LILLY : PHASE 3 TRIALS OF ONCE-WEEKLY INSULIN IN TYPE 2 DIABETES MEETS PRIMARY ENDPOINT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ELI LILLY | 858560 | Xetra | 820,300 | 24.09.24 16:47:00 | -3,600 | -0,44% | 820,100 | 820,900 | 828,300 | 823,900 |
